RAB14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.516600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.425000E-01
Normal-vs-Stage2
6.397000E-01
Normal-vs-Stage3
8.815600E-02
Normal-vs-Stage4
7.353400E-01
Stage1-vs-Stage2
9.718400E-01
Stage1-vs-Stage3
1.268600E-01
Stage1-vs-Stage4
4.237800E-01
Stage2-vs-Stage3
8.605700E-02
Stage2-vs-Stage4
2.949800E-01
Stage3-vs-Stage4
9.078200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.133600E-01
Normal-vs-AfricanAmerican
9.287800E-01
Normal-vs-Asian
7.466000E-01
Caucasian-vs-AfricanAmerican
6.089200E-01
Caucasian-vs-Asian
8.551400E-01
AfricanAmerican-vs-Asian
8.044400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.855000E-01
Normal-vs-Female
6.177800E-01
Male-vs-Female
8.470600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.507200E-01
Normal-vs-Age(41-60Yrs)
8.214000E-01
Normal-vs-Age(61-80Yrs)
4.568200E-01
Normal-vs-Age(81-100Yrs)
2.315200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.495800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.624000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.323000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
7.399300E-04
Age(41-60Yrs)-vs-Age(81-100Yrs)
4.915500E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.991800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.753600E-01
Normal-vs-Daily Drinker
4.798800E-01
Normal-vs-Weekly Drinker
2.979000E-01
Normal-vs-Occasional Drinker
9.937800E-01
Normal-vs-Social Drinker
8.838000E-01
Non Drinker-vs-Daily Drinker
6.258800E-01
Non Drinker-vs-Weekly Drinker
8.878200E-01
Non Drinker-vs-Occasional Drinker
7.883900E-02
Non Drinker-vs-Social Drinker
1.974190E-01
Daily Drinker-vs-Weekly Drinker
5.685800E-01
Daily Drinker-vs-Occasional Drinker
1.926810E-01
Daily Drinker-vs-Social Drinker
3.819200E-01
Weekly Drinker-vs-Occasional Drinker
9.353700E-02
Weekly Drinker-vs-Social Drinker
2.132600E-01
Occasional Drinker-vs-Social Drinker
7.778400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.125600E-02
Normal-vs-Grade 2
1.685570E-02
Normal-vs-Grade 3
1.305780E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.811570E-01
Grade 1-vs-Grade 3
1.271240E-01
Grade 1-vs-Grade 4
8.125600E-02
Grade 2-vs-Grade 3
6.612800E-01
Grade 2-vs-Grade 4
1.685570E-02
Grade 3-vs-Grade 4
1.305780E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.838200E-01
Normal-vs-NonDiabetic
6.082600E-01
Diabetic-vs-NonDiabetic
4.505400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.034200E-01
Normal-vs-NoPancreatitis
6.391800E-01
Pancreatitis-vs-NoPancreatitis
5.476800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.420200E-01
Normal-vs-N1
6.334600E-01
N0-vs-N1
6.677600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.901600E-01
Normal-vs-TP53-NonMutant
7.612200E-01
TP53-Mutant-vs-TP53-NonMutant
3.415000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
